These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 8758899
1. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis. Tanaka S, Wands JR. Cancer Res; 1996 Aug 01; 56(15):3391-4. PubMed ID: 8758899 [Abstract] [Full Text] [Related]
2. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. Tanaka S, Mohr L, Schmidt EV, Sugimachi K, Wands JR. Hepatology; 1997 Sep 01; 26(3):598-604. PubMed ID: 9303488 [Abstract] [Full Text] [Related]
3. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Chen RH, Su YH, Chuang RL, Chang TY. Oncogene; 1998 Oct 15; 17(15):1959-68. PubMed ID: 9788439 [Abstract] [Full Text] [Related]
4. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways. Lin SJ, Chang C, Ng AK, Wang SH, Li JJ, Hu CP. Apoptosis; 2007 Sep 15; 12(9):1659-70. PubMed ID: 17624592 [Abstract] [Full Text] [Related]
5. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Fan G, Ma X, Kren BT, Steer CJ. Oncogene; 1996 May 02; 12(9):1909-19. PubMed ID: 8649852 [Abstract] [Full Text] [Related]
6. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD. J Immunol; 1996 Dec 01; 157(11):4926-34. PubMed ID: 8943397 [Abstract] [Full Text] [Related]
7. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells. Banerjee K, Mohr L, Wands JR, de la Monte SM. Alcohol Clin Exp Res; 1998 Dec 01; 22(9):2093-101. PubMed ID: 9884156 [Abstract] [Full Text] [Related]
8. Involvement of the actin network in insulin signalling. Tsakiridis T, Wang Q, Taha C, Grinstein S, Downey G, Klip A. Soc Gen Physiol Ser; 1997 Dec 01; 52():257-71. PubMed ID: 9210235 [Abstract] [Full Text] [Related]
9. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S. Oncogene; 2006 Oct 05; 25(45):6101-12. PubMed ID: 16682950 [Abstract] [Full Text] [Related]
10. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC. J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031 [Abstract] [Full Text] [Related]
11. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways. Sorokin A, Reed E, Nnkemere N, Dulin NO, Schlessinger J. Oncogene; 1998 May 14; 16(19):2425-34. PubMed ID: 9627109 [Abstract] [Full Text] [Related]
12. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Park HJ, Kim BC, Kim SJ, Choi KS. Hepatology; 2002 Jun 14; 35(6):1360-71. PubMed ID: 12029621 [Abstract] [Full Text] [Related]
13. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, Wands JR. J Hepatol; 2006 May 14; 44(5):971-83. PubMed ID: 16564107 [Abstract] [Full Text] [Related]
15. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules. Tanaka S, Ito T, Wands JR. J Biol Chem; 1996 Jun 14; 271(24):14610-6. PubMed ID: 8662827 [Abstract] [Full Text] [Related]